Adjustment of 2025 full-year financial targets Villepinte, 15 September 2025, 5.45 p.m.: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, is announcing a downward revision to its financial targets for full-year 2025. Business activity in France continues to be impacted by supply reforms. In the United States, an unfavourable shift in the customer mix, with distributors representing a higher proportion of sales and ongoing pricing pressures has added to ...